COMPASS Pathways plc (CMPS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CMPS currently has 129M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 78.3% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 24, 2026 |
10-K filing | 128.9M shares outstanding |
130M | 0 |
| Jul 31, 2025 |
10-Q filing | 93.3M shares outstanding |
93M | 3.2M |
| May 08, 2025 |
10-Q filing | 89.2M shares outstanding |
89M | 7.3M |
| Feb 27, 2025 |
10-K filing | 92.7M shares outstanding |
93M | 3.8M |
| Feb 27, 2025 |
S-3 filing: The filing is an S-3 form for an at-the-market offering of ordinary shares represented by ADSs, with an aggregate offering price of up to $150,000,000, to be made through sales agent TD Securities (USA) LLC. |
68M | 28M |
| Oct 31, 2024 |
10-Q filing | 68.4M shares outstanding |
68M | 28M |
| Oct 07, 2024 |
S-3 filing: The company is offering ordinary shares represented by ADSs through an at-the-market offering with TD Securities (USA) LLC as the sales agent, with a total proposed amount of up to $93,512,230. The company intends to use the net proceeds from this offering primarily for general corporate purposes. |
68M | 28M |
| Aug 01, 2024 |
10-Q filing | 68.4M shares outstanding |
68M | 12M |
| May 08, 2024 |
10-Q filing | 64.2M shares outstanding |
64M | 16M |
| Feb 29, 2024 |
10-K filing | 64.2M shares outstanding |
64M | 16M |
| Nov 02, 2023 |
10-Q filing | 61.9M shares outstanding |
62M | 19M |
| Sep 08, 2023 |
S-3 filing: This is an S-3 filing for a shelf offering of up to 40,089,163 ADSs, each representing one ordinary share. |
46M | 35M |
| Aug 16, 2023 |
8-K filing: COMPASS Pathways plc entered into a Securities Purchase Agreement to sell and issue 16,076,750 American Depositary Shares and warrants to purchase up to 16,076,750 ADSs at a purchase price of approximately $7.78 per ADS and accompanying Warrant, with gross proceeds expected to be approximately $125.0 million. ($125.0M proceeds) |
46M | 0 |
| Aug 03, 2023 |
10-Q filing | 45.6M shares outstanding |
46M | 0 |
| Jul 05, 2023 |
8-K filing: COMPASS Pathways plc entered into a loan and security agreement with Hercules Capital, Inc. and issued a warrant to Hercules for 94,222 ordinary shares at an exercise price of $7.96 per share. |
43M | 0 |
| May 11, 2023 |
10-Q filing | 42.7M shares outstanding |
43M | 0 |
| Feb 28, 2023 |
10-K filing | 42.4M shares outstanding |
42M | 0 |
| Nov 03, 2022 |
10-Q filing | 42.5M shares outstanding |
43M | 0 |
| Aug 04, 2022 |
10-Q filing | 42.5M shares outstanding |
42M | 0 |
| May 10, 2022 |
10-Q filing | 42.0M shares outstanding |
42M | 0 |
| Feb 24, 2022 |
10-K filing | 40.0M shares outstanding |
40M | 530K |
| Feb 24, 2022 |
POS AM filing: This POS AM filing relates to an at-the-market offering of ordinary shares represented by ADSs, with an aggregate offering price of up to $150,000,000, to be made through Cowen and Company, LLC. |
42M | 0 |
| Apr 27, 2021 |
F-1 filing: This F-1 filing from Compass Pathways details the offering of 4,000,000 ADSs at $35.30 per ADS, with an underwriter option for an additional 600,000 ADSs, to fund clinical trials, research, business development, and general expenses. |
36M | 4.6M |
| Mar 09, 2021 |
20-F filing | 35.9M shares outstanding |
36M | 0 |